Moderna, Inc. (MRNA) Stock Profile — Insider Trades & Financials

Revenue$678.0M

Net Income-$826.0M

EPS$-7.26

Market Cap$19.8B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Stéphane Bancel

CEO & Executive Director

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

Employees: 680
Headquarters: CAMBRIDGE, MA, United States
Website: www.modernatx.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-9.55%

ROA?

-6.69%

D/E Ratio?

0.43

Op. Margin?

-126.40%

📊

Profitability Ratios

Net Margin?

-121.83%

Loading company sections...

Moderna, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness